As of Nov 19, 2026, 1 of 2 active firms rate GOVX a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
GOVX EPS & revenue forecast
EPS · NEXT QUARTER
$-15.12
Range $-15.12 – $-15.12 · 1 analysts · -76% YoY
Next period, 1 analysts expect GeoVax Labs Inc to earn $-15.12 a share (range $-15.12 – $-15.12), versus $-62.88 a year earlier. Full-year consensus is $-123.36, growing to $-68.52 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 1 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering GeoVax Labs Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on GOVX.
#1
Jason Kolbert
D. Boral Capital · Rank #562
Neutral
$1.00-50.0% to target
Overall win rate
22%
+ Follow
#2
Vernon Bernardino
HC Wainwright & Co. · Rank #582
Buy
$8.00+300.0% to target
Overall win rate
14%
+ Follow
#3
James Molloy
Alliance Global Partners · Rank #587
Buy
$212.50+10525.0% to target
Overall win rate
25%
+ Follow
#4
Jonathan Aschoff
Roth MKM · Rank #588
Buy
$240.00+11900.0% to target
Overall win rate
28%
+ Follow
#5
RL
Robert LeBoyer
Noble Capital Markets
Buy
$10.00+400.0% to target
Coverage
—
+ Follow
GOVX stock forecast FAQ
What is GOVX's average 12-month price target?+
The 2 active firms with a live target average $5.50 for GeoVax Labs Inc over the next 12 months, ranging from a $10.00 high to a $1.00 low, as of Nov 19, 2026.
Is GOVX stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 2 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for GOVX?+
The Street-high target is $10.00 (Noble Capital Markets), and the Street-low is $1.00 (D. Boral Capital). The average of all 2 active-firm targets is $5.50.
How many active Wall Street firms cover GOVX?+
2 active firms have a recognized rating on GeoVax Labs Inc as of Nov 19, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering GOVX?+
Among analysts who currently cover GOVX, Jason Kolbert of D. Boral Capital has the strongest overall Quantellect track record (Rank #562). Their current call is Neutral with a $1.00 target.
What is GeoVax Labs Inc's projected EPS for next quarter?+
The consensus estimate is $-15.12 per share (range $-15.12 – $-15.12) across 1 analysts. Full-year EPS is projected at $-123.36, rising to $-68.52 the following year.
How much revenue is GeoVax Labs Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading GOVX lately?+
As of Nov 19, 2026, 1 of 2 active firms rate GOVX a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their GOVX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.